Benzinga - On Tuesday, Cathie Wood-led Ark Invest made a significant purchase of Roku Inc (NASDAQ:ROKU) shares. This decision comes amidst a period of market volatility and recent bearish sentiments from analysts toward Roku’s revenue growth prospects.
The Roku Trade
Ark Invest’s acquisition of Roku shares stands out as the day’s most notable transaction. The investment firm purchased $16.9 million of Roku stock across multiple funds, including Ark Fintech Innovation ETF (NYSE:ARKF), ARK Innovation ETF (NYSE:ARKK), and ARK Next Generation Internet ETF (NYSE:ARKW). On Tuesday, Roku stock closed 2.9% lower at $89.
This move is particularly intriguing given the recent skepticism from analysts regarding Roku’s economic viability in the face of stiff competition and a challenging advertising market.
Other Key Trades:
- Sold shares of Coinbase Global Inc (NASDAQ:COIN) across ARKF, ARKK, and ARKW funds worth $527,116.
- Bought shares of Recursion Pharmaceuticals (NASDAQ:RXRX) in the ARKK fund.
- Sold shares of Exact Sciences Corp (NASDAQ:EXAS) in the ARKK fund.
- Bought shares of Rocket Lab USA Inc (NASDAQ:RKLB) in the ARKQ fund.
- Sold shares of Stratasys Ltd (NASDAQ:SSYS) in both ARKQ and ARKX funds.
- Sold shares of Robinhood Markets Inc (NASDAQ:HOOD) in the ARKW fund worth $292,006.
See Also: Cathie Wood, Elon Musk To Talk AI, Space, And More On X Spaces This Week
Ark Invest’s trading activities, particularly in the tech sector, have been closely monitored by investors seeking insights into emerging trends and potential growth areas. The firm’s latest trades, especially the substantial investment in Roku, reflect its ongoing strategy of focusing on innovative companies poised for long-term growth.
Read Next: Ark Invest’s Cathie Wood Doubles Down On Yahoo Japan Operator After A Year-Long Hiatus
Engineered by Benzinga Neuro, Edited by
Shivdeep Dhaliwal
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you.
Learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.